Efficacy of azithromycin in severe asthma from the AMAZES randomised trial
Background Low-dose azithromycin is an effective therapy for persistent asthma; however, its benefit in severe asthma is not defined. Methods Participants with severe asthma were identified from the AMAZES randomised, placebo-controlled trial of long-term (48 weeks) low-dose azithromycin. Participan...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2019-12-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/5/4/00056-2019.full |